Signatera by Natera vs Freenome

Side-by-side comparison of cancer screening tests.

← Back to Cancer Screening

Signatera by Natera

FDA approved (MRD)
Variable

Patient-specific

Freenome

In development
Variable

Multiple

Test Performance

FeatureSignatera by NateraFreenome
PriceVariableVariable
Cancers DetectedPatient-specificMultiple
SensitivityVaries by cancerNot disclosed
Specificity>99.8%Not disclosed
Sample TypeBlood drawBlood draw
FDA StatusFDA approved (MRD)In development